1. Home
  2. CBL vs CRGX Comparison

CBL vs CRGX Comparison

Compare CBL & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBL
  • CRGX
  • Stock Information
  • Founded
  • CBL 1978
  • CRGX 2021
  • Country
  • CBL United States
  • CRGX United States
  • Employees
  • CBL N/A
  • CRGX N/A
  • Industry
  • CBL Real Estate Investment Trusts
  • CRGX
  • Sector
  • CBL Real Estate
  • CRGX
  • Exchange
  • CBL Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • CBL 813.3M
  • CRGX 964.5M
  • IPO Year
  • CBL 1993
  • CRGX 2023
  • Fundamental
  • Price
  • CBL $27.25
  • CRGX $16.00
  • Analyst Decision
  • CBL
  • CRGX Strong Buy
  • Analyst Count
  • CBL 0
  • CRGX 7
  • Target Price
  • CBL N/A
  • CRGX $30.33
  • AVG Volume (30 Days)
  • CBL 103.4K
  • CRGX 167.8K
  • Earning Date
  • CBL 11-11-2024
  • CRGX 11-12-2024
  • Dividend Yield
  • CBL 5.87%
  • CRGX N/A
  • EPS Growth
  • CBL N/A
  • CRGX N/A
  • EPS
  • CBL 1.01
  • CRGX N/A
  • Revenue
  • CBL $523,580,000.00
  • CRGX N/A
  • Revenue This Year
  • CBL N/A
  • CRGX N/A
  • Revenue Next Year
  • CBL N/A
  • CRGX N/A
  • P/E Ratio
  • CBL $26.97
  • CRGX N/A
  • Revenue Growth
  • CBL N/A
  • CRGX N/A
  • 52 Week Low
  • CBL $20.97
  • CRGX $13.56
  • 52 Week High
  • CBL $28.50
  • CRGX $33.92
  • Technical
  • Relative Strength Index (RSI)
  • CBL 55.53
  • CRGX 32.69
  • Support Level
  • CBL $25.92
  • CRGX $19.96
  • Resistance Level
  • CBL $28.50
  • CRGX $23.00
  • Average True Range (ATR)
  • CBL 0.57
  • CRGX 1.79
  • MACD
  • CBL -0.04
  • CRGX -0.58
  • Stochastic Oscillator
  • CBL 51.55
  • CRGX 7.04

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a U.S.-based real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

Share on Social Networks: